Karjäär B.Braunis Leia oma võimalused
Kanname hoolt inimeste tervise eest igas maailma nurgas
Choose a category or subcategory
2018 fiscal year: B. Braun increases sales and invests over 1.2 billion euros
Melsungen. B. Braun Melsungen AG completed the fiscal year 2018 with total sales of € 6,908 million (previous year: € 6,789 million). Sales increased from the previous year by 1.8 percent (currency-adjusted, +5.3 percent). EBITDA fell 3.3 percent from the previous year with € 952.5 million.
20 Years of NuTRIflex Three-Chamber Bags: The Integrated, Ready-for-Use System for Parental Nutrition
20 years ago, B. Braun introduced the first standardized three-chamber bag to the European market for patients who are reliant on parental nutrition. NuTRIflex three-chamber bags are manufactured in Melsungen and sold in 50 countries around the world.
Anna Maria Braun to succeed Heinz-Walter Große as Chairman of the Management Board of B. Braun Melsungen AG in April 2019
The Supervisory Board of B. Braun Melsungen AG decided in its meeting of today that Anna Maria Braun (39) will assume the Chairmanship of the Management Board of B. Braun Melsungen AG effective April 1st, 2019.
Personalized cancer therapy: B. Braun and CeGaT found joint venture CeCaVa
Melsungen/Tübingen – The medical technology and pharmaceutical manufacturer B. Braun Melsungen AG and CeGaT GmbH in Tübingen have announced the creation of the joint venture CeCaVa GmbH & Co. KG.
Innovative solutions and exiting entrepreneurs: B. Braun Accelerator Demo Day
Melsungen. Innovative ideas can come from all sorts of directions – you just have to confront them with courage and openness. This was impressively underscored by “Demo Day” on Thursday, August 30th when the results of the first round of the B. Braun Accelerators were presented.
B. Braun inaugurates Europe’s most modern production site in Saxony
Wilsdruff/Melsungen. On September 4th, B. Braun Melsungen AG opened up Europe’s most modern production site for dialyzers with a celebratory inauguration event in Wilsdruff. Dialyzers are filter units for the dialysis of people with chronic kidney failure. With this investment, B. Braun hopes to double its production capacity in Saxony.
Drug-coated Balloon SeQuent® Please Shows Positive Results in Largest Randomized Clinical Trial
Munich, August 28th: Prof. Raban Jeger from the University Hospital Basel (Switzerland) reported the late breaking results from the BASKET-SMALL 2 trial at the ESC congress in Munich, Germany.
Personnel Changes in Supervisory and Management Board of Aesculap AG
With a meeting on July 10, Professor Ludwig Georg Braun ended his mandate as chairman of the Supervisory Board of Aesculap AG. After more than 42 years of being a member, Professor Braun decided not to stand for re-election. With immediate efficiency, Prof. Dr. Heinz Walter Grosse, Chairman of the Management Board of B. Braun Melsungen AG, was unanimously elected to his position.
EU Commissioner Andriukaitis meets leading players of the Tuttlingen medical technology cluster
Following the invitation of the local Member of the European Parliament Dr. Andreas Schwab, Vytenis Andriukatis, EU Commissioner for Health and Food Safety, visited the medical technology industry in Tuttlingen.